Abstract
Rabeprazole, a proton pump inhibitor, was labeled with 131I to give 131I-rabeprazole in 98% yield. The optimum conditions were as follows: pH 8, 100 μg of chloramine-T, 30 min, and 0.2 mg of rabeprazole. The labeled compound was stable for 24 h. Biodistribution of 131I-rabeprazole in mice after intravenous injection was studied, and its high uptake in stomach ulcer, reaching approximately 38% ID/g at 1 h post injection, was demonstrated. This concentration of the labeled compound in stomach ulcer is sufficient for ulcer imaging. The advantages of the method are simple labeling procedure, high labeling yield, and high sensitivity of ulcer imaging.
Similar content being viewed by others
References
Merck Index, London: Merck, 2011, 13th ed., p. 1450.
Jungnickel, P.W., Clin. Ther., 2000, vol. 22, p. 1268.
Cheer, S.M., Prakash, A., Faulds, D., and Lamb, H.M., Drugs, 2003, vol. 63, p. 101.
Patel, B.H., Suhagia, B.N., Patel, M.M., and Patel, J.R., J. Liq. Chromatogr. Relat. Tech., 2007, vol. 30, no. 3, pp. 439–445.
Snowden, F.M., Immunol. Rev., 2008, vol. 1, p. 9.
Loughlin, M.F., Ala’Aldeen, D.A., and Jenks, P.J., J. Antimicrob. Chemother., 2003, vol. 2, p. 367.
Bebb, J.R., Bailey-Flitter, N., Ala’Aldeen, D., and Atherton, J.C., J. Antimicrob. Chemother., 2003, vol. 3, p. 522.
Traversa, G., Walker, A.M., Ippolito, F.M., et al., Epidemiology, 1995, vol. 1, p. 49.
Snowden, F.M., Immunol. Rev., 2008, vol. 1, p. 9.
Loughlin, M.F., Ala’Aldeen, D.A., and Jenks, P.J., J. Antimicrob. Chemother., 2003, vol. 2, p. 367.
Bebb, J.R., Bailey-Flitter, N., Ala’Aldeen, D., and Atherton, J.C., J. Antimicrob. Chemother., 2003, vol. 3, p. 522.
Sanad, M.H., Radiochemistry, 2013, vol. 55, no. 6, pp. 605–609.
Sanad, M.H. and Ibrahim, I.T., Radiochemistry, 2013, vol. 55, no. 3, pp. 341–345.
Sanad, M.H. and Ibrahim, I.T., Radiochemistry, 2015, vol. 57, no. 4, pp. 425–430.
Amin, A.M., Omar, M.M., Abd-Elhaliem, S.M., and Elshanawany, A.A., Radiochemistry, 2015, vol. 57, no. 2, pp. 182–186.
Nicolaus, B.J.R., Drug Devel. Res., 1982, vol. 2, no. 5, pp. 463–474.
Hupf, H.B., Eldridge, J.S., and Beaver, J.E., Int. J. Appl. Radiat. Isot., 1968, vol. 19, no. 4, pp. 345–351.
Sanad, M.H., Motaleb, M.A., and Marzook, F., Radiochim. Acta, 2016, vol. 104, no. 5, pp. 345–353.
Sanad, M.H., Sallam, Kh.M., Marzook, F.A., and Abd-Elhaliem, S.M., J. Label. Compd. Radiopharm., 2016, vol. 59, pp. 484–491.
Khokra, S.L., Choudhary, B., and Mehta, H., Int. Curr. Pharm. J., 2012, vol. 1, no. 12, pp. 410–413.
Ogawa, R. and Echizen, H., Clin. Pharmacokinet., 2010, vol. 49, pp. 509–533.
Iwahi, T., Satoh, H., Nakao, M., et al., Antimicrob. Agents Chemother., 1991, vol. 35, pp. 490–496.
Fellenius, E., Berglindh, T., Sachs, G., et al., Nature (London), 1981, vol. 290, pp. 159–161.
Ferrero, R.L., Cussac, V., Courcoux, P., and Labigne, A., J. Bacteriol., 1992, vol. 174, pp. 4212–4217.
Ferrero, R.L. and Lee, A., Microb. Ecol. Health Dis., 1991, vol. 4, pp. 121–134.
Fryklund, J., Gedda, K., and Wallmark, B., Biochem. Pharmacol., 1988, vol. 37, pp. 2543–2549.
Sanad, M.H., El-Bayoumy, A.S.A., and Ibrahim, A.A., J. Radioanal. Nucl. Chem., 2017, vol. 311, no. 1, pp. 1–14.
Abi-Dargham, A., Zea-Ponce, Y., Terriere, D., et al., Eur. J. Pharmacol., 1997, vol. 321, no. 3, p. 285.
Author information
Authors and Affiliations
Corresponding author
Additional information
The text was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
Sanad, M.H., Challan, S.B. Radioiodination and biological evaluation of rabeprazole as a peptic ulcer localization radiotracer. Radiochemistry 59, 307–312 (2017). https://doi.org/10.1134/S1066362217030158
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362217030158